Farms.com Home   News

World’s Tiniest Library Could Be Key to Saving Millions of Cattle

One of the world’s smallest and strangest bacteria also is responsible for one of the most devastating cattle diseases.

The tiny bacteria, Mycoplasma mycoides subspecies mycoides (Mmm), cause contagious bovine pleuropneumonia (CBPP) when inhaled by cattle.

CBPP is a huge barrier to cattle farming in sub-Saharan Africa, where it is endemic in at least 12 countries. It is estimated to cost the continent over 38.8 million United States dollars a year.

To fully understand these deadly bacteria, and pave the way to developing a better vaccine, scientists at the International Livestock Research Institute (ILRI) are constructing a full library of their genes and their possible functions.

Cattle with CBPP develop painful and inflamed, fluid-filled lungs, causing difficulty breathing and coughing.

CBPP can infect nearly all of a herd and kill up to 50% of animals. Those that survive become weakened, and some may become chronic carriers that will breathe the bacteria onto other naive cattle.

Disease symptoms may appear several days to months following infection, so traditional methods of pastoralism and moving cattle over long distances can contribute to its spread.

Although a vaccine is available, it has limited efficacy, and sometimes causes severe side effects which can make pastoralists reluctant to use it.

Mmm are part of a class of bacteria called mollicutes. In addition to lacking a cell wall—usually a widespread feature of bacteria—mollicutes have especially small genomes, by bacterial standards.

Click here to see more...

Trending Video

Intrauterine Vaccines in Swine - Dr. Heather Wilson

Video: Intrauterine Vaccines in Swine - Dr. Heather Wilson



In this episode of The Swine it Podcast Show Canada, Dr. Heather Wilson from VIDO at the University of Saskatchewan explains how intrauterine vaccination is being developed as a new option for swine health. She shares how formulation, adjuvants, and delivery methods influence immune responses and what early trials reveal about safety and reproductive performance. Listen now on all major platforms.

"The idea was that an intrauterine vaccine might avoid a tolerance response and instead create an active immune response."

Meet the guest: Dr. Heather Wilson / heather-wilson-a8043641 is a Senior Scientist and Program Manager at the Vaccine and Infectious Disease Organization at the University of Saskatchewan. Her work centers on vaccine formulation and delivery in pigs, including the development of intrauterine vaccination to support reproductive health and passive protection of piglets. Her background spans biochemistry, immunology, and functional pathogenomics.